Revive Therapeutics Advances Inflammatory Liver Disorders Programs for Autoimmune Hepatitis and Liver Transplantation May 31, 2022
HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S. Market Feb 10, 2022